New SoCal Biotech Launches With $55.3M Backed by Novartis, Sanofi and 5AM Ventures Post author:Sam Post published:January 2, 2018 Post category:BioPharma The round was co-led by 5AM Ventures, Kleiner Perkins, Novartis Venture Fund, and Sanofi Ventures. Source: BioSpace You Might Also Like AstraZeneca PLC CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo July 20, 2017 Celgene ReleaseData Presented At 2017 Further Evaluate Role Of ABRAXANE For Patients With Historically Challenging Cancers September 7, 2017 AbbVie Presents New Phase 2b Data on Upadacitinib in Atopic Dermatitis February 18, 2018
AstraZeneca PLC CEO Breaks Silence on Teva Rumors, Urges Staff to Remain Focused in Leaked Memo July 20, 2017
Celgene ReleaseData Presented At 2017 Further Evaluate Role Of ABRAXANE For Patients With Historically Challenging Cancers September 7, 2017